Although direct clinical evidence for anti-HCC activity in humans is lacking, its ability to attenuate insulin resistance, oxidative stress, and the inflammation-fibrosis cascade may indirectly reduce HCC risk by optimizing the hepatic oncogenic microenvironment
Zheng YJ, Soegiharto C, Au HCT, Valentino K, Le GH, Wong S, et al
Dont waste your money
These changes can increase hunger signals and reduce satiety, partially counteracting the appetite-suppressing effects of GLP-1 medications
Confirm the exact draw with your provider before injecting
Preserved lean mass must empower movement, reduce falls, and sustain independence, especially in older adults